Search clinical trials for: DMMET-01

Total 553 results

Laboratorios Silanes S.A. de C.V.

Completed

Gastric Tolerability and Pharmacokinetics of DMMET-01

Healthy

Mexico
Laboratorios Silanes S.A. de C.V.

Completed

Effect of DMMET-01 on Insulin Sensitivity in Naive Type 2 Diabetes Patients (CLAMP) (DMMETclamp)

Diabetes Type 2

Mexico
Laboratorios Silanes S.A. de C.V.

Completed

Study on DMMET-01 Versus Metformin on Improvement of Metabolic Control in Naive Type 2 Diabetes Patients (DMMET2)

Diabetes Type 2

Mexico
Laboratorios Silanes S.A. de C.V.
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Unknown

Efficacy Study of Metformin Glycinate on Postprandial Lipemia

Type 2 Diabetes

Mexico
Infectopharm Arzneimittel GmbH

Recruiting

Comparative Head Lice Therapy With Dimet 5® vs. Hedrin® Once (VEKODIH)

Pediculosis Capitis | Head Lice Infestation | Lice

Germany
Livzon Pharmaceutical Group Inc.

Active, not recruiting

A Preliminary Exploratory Study to Evaluate the Safety and Immunogenicity of Omicron Variant Bivalent Vaccine V-01-B5 (COVID-19)

COVID-19 Pandemic

China
Zucara Therapeutics Inc.

Recruiting

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes (ZONE)

Type 1 Diabetes Mellitus With Hypoglycemia

United States, Canada
Ixchelsis Limited

Completed

IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)

Premature Ejaculation

United States
Laboratorios Silanes S.A. de C.V.

Completed

Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2. (DMMETCOV19-2)

Severe Acute Respiratory Syndrome Coronavirus 2

Mexico
Laboratorios Silanes S.A. de C.V.

Withdrawn

Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2 (DMMETCOV19)

Metabolic Syndrome | Type 2 Diabetes | Severe Acute Respiratory Syndrome Coronavirus 2

Mexico
Shanghai Hongyitang Biopharmaceutical Technology...

Completed

A Phase IIa Clinical Trial on TSG-01 in the Treatment of Chronic Heart Failure in Patients With Coronary Heart Disease.

Chronic Heart Failure

China
Enterin Inc.

Terminated

Orally Administered ENT-01 for Parkinson's Disease-Related Constipation Follow-on Safety "Roll-over" Study (Rollover) (Rollover)

Parkinson Disease | Constipation

United States
Zhongmou Therapeutics

Recruiting

Safety and Efficacy Study of Novel Gene Therapy ZM-01 for X-linked Retinoschisis Patients

X-linked Retinoschisis

China
BioPharmX, Inc.

Completed

BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes

Acne Vulgaris

United States
Enterin Inc.

Completed

Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET) (KARMET)

Parkinson Disease | Constipation

United States
Shenzhen Yangli Pharmaceutical Technology Co., Ltd

Recruiting

A Study of TFX05-01 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Radboud University Medical Center
CATO-SMS

Recruiting

Dose Escalation Study of Immunomodulatory Nanoparticles (PRECIOUS-01)

Advanced Solid Tumor

Netherlands
Joanne Kurtzberg, MD
The Marcus Foundation

Recruiting

UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells (DUOC-01)

Mucopolysaccharidosis II | Brain Diseases, Metabolic, Inborn | Adrenoleukodystrophy | Batten Disease | Leukodystrophy, Metachromatic | Leukodystrophy, Globoid Cell | Alpha-Mannosidosis | Tay-Sachs Disease | Pelizaeus-Merzbacher Disease | Sandhoff Disease | Neimann Pick Disease | Sanfilippo Mucopolysaccharidoses

United States
SQ Innovation, Inc.
EB Medical Research; Quartesian

Completed

A Safety/Tolerance Phase, Ascending Single Dose Study to Evaluate the Safety and Tolerability of G3P-01, a Food-Grade Pectic Product, in Healthy Volunteers (G3P-01-01)

Gastrointestinal Discomfort | Performance Status

Netherlands
Alexander Kolevzon

Completed

AMO-01 to Treat Adolescents and Adults With Phelan-McDermid Syndrome (PMS) and Co-morbid Epilepsy

Epilepsy | Phelan-McDermid Syndrome

United States
Personalized Stem Cells, Inc.

Unknown

Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis

Knee Osteoarthritis

United States
Ixchelsis Limited

Completed

Relative Bioavailability and Food Effect Study of IX-01 Capsules in Healthy Men

Healthy Participants

United Kingdom
Organogenesis

Terminated

Safety Study of VCT-01™ in Split-Thickness Skin Graft Donor Site Wounds

Wounds

Canada
Afexa Life Sciences Inc

Completed

LIP-01 in Hypercholesterolemia

Hypercholesterolemia

Canada, United States
NC Medial Research Inc

Recruiting

A Study of NCS-01 in Patients With Acute Ischemic Stroke

Ischemic Stroke

United States
Leap Therapeutics, Inc.

Available

Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors

Gastric Cancer | Ovarian Cancer | Gastric Adenocarcinoma | Carcinosarcoma | Endometrial Cancer | Adenocarcinoma of the Gastroesophageal Junction | GastroEsophageal Cancer | Uterine Cancer | Esophageal Neoplasm | Squamous Cell Carcinoma

United States
EdiGene (GuangZhou) Inc.
PLA 923 Hospital

Active, not recruiting

A Study to Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects With Transfusion Dependent β-Thalassaemia.

Transfusion Dependent Beta-Thalassaemia

China
Shanghai De Novo Pharmatech Co., Ltd.

Completed

A Study to Evaluate the Safety, Tolerability of DN1508052-01 in Advanced Solid Tumors

Advanced Solid Tumors

United States
Sofregen Medical, Inc.
Symbio, LLC

Active, not recruiting

Preliminary Safety and Effectiveness of SMI-01 as a Tissue Filler

Nasolabial Fold | Cheek Augmentation

United States
Nihon Pharmaceutical Co., Ltd

Completed

Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré Syndrome

Guillain-Barré Syndrome

Japan
Johnson & Johnson K.K. Medical Company

Completed

Reperfuse Ischemic Vessels With Endovascular Recanalization Device in JAPAN (RIVER JAPAN)

Acute Ischemic Stroke

Japan
BioPharmX, Inc.

Completed

BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris (OPAL)

Acne Vulgaris

United States
Vedic Lifesciences Pvt. Ltd.

Completed

A Study to Evaluate the Efficacy of E-PR-01 on Musculoskeletal Health in Physically Active Individuals

Joint Pain

India
Hokkaido University Hospital
Japan Agency for Medical Research and Development

Recruiting

Intracerebral Transplantation of Autologous MSC Combined With Scaffold Product for Chronic Intracerebral Hemorrhage (RAINBOW-Hx)

Intracerebral Hemorrhage

Japan
Valerio Therapeutics

Recruiting

A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors

Breast Cancer | Prostate Cancer | Advanced or Metastatic Solid Tumors | Recurrent Ovarian Cancer

United States
Fundació Sant Joan de Déu

Recruiting

Evaluate Safety and the Oncolitic Adenovirus VCN-01 Activity in Patients With Refractory Retinoblastoma (RTB)

Retinoblastoma, Recurrent

Spain
Institute of Hematology & Blood Diseases Hospital...
EdiGene Inc.; The Affiliated Hospital Of Guizhou Medical University; Zunyi Medical...

Active, not recruiting

Safety and Efficacy Evaluation of ET-01 Transplantation in Subjects With Transfusion Dependent β-Thalassaemia

Transfusion Dependent Beta-Thalassaemia

China
New Epsilon Innovation Limited

Active, not recruiting

An Early Phase Study of NEI-01 in Patients With Solid Tumors or Acute Myeloid Leukemia

Advanced Solid Tumor | Relapsed AML | Refractory AML

Hong Kong
University of Virginia

Terminated

Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer

Pancreatic Ductal Adenocarcinoma

United States
Washington University School of Medicine

Completed

A Phase I Study of Bi-Weekly rBBX-01 in Patients With Solid Tumors

Solid Tumors

United States
Resistentia Pharmaceuticals AB

Completed

Safety Study of Anti-IgE Immunotherapy in Allergic Patients

Allergy

New Zealand
GLWL Research Inc.

Terminated

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GLWL-01

Diabetes Mellitus, Type 2

United States
Cerecin
Celerion

Completed

Study to Compare the Pharmacokinetics of AC 1202 and Two Doses of AC-SD-01 on Ketone Body Production

Healthy

United States
AVROBIO

Terminated

Open Label, Study Of Efficacy and Safety Of AVR-RD-01 for Treatment-Naive Subjects With Classic Fabry Disease

Fabry Disease

United States, Australia, Brazil
RepliCel Life Sciences, Inc.
Syreon Corporation; Innovacell Biotechnologie AG

Terminated

Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis (ReaCT)

Tendinopathy | Tendinosis

Canada
Ixchelsis Limited

Completed

A Study of Multiple Oral Doses of IX-01 in Healthy Male Subjects

Healthy Volunteers

United Kingdom
Ixchelsis Limited

Completed

A Study of Multiple Oral Doses of IX-01 in Healthy Men

Healthy Participants

United Kingdom
Mitos Pharmaceuticals

Terminated

Safety and Preliminary Efficacy Study of MTS-01 for the Prevention of Alopecia Induced by WHole Brain Radiotherapy

Alopecia
MC2 Therapeutics

Completed

Evaluation of Potential Phototoxicity Skin Reaction After Use of MC2-01 Cream

Phototoxicity

United States
Maxinovel Pty., Ltd.

Recruiting

Study of MAX-40279 in Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)

AML

China

Search clinical trials for: DMMET-01

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations